Malignant lymphoma of lymphocytic type (MLLKiel; WDLL -Rappaport) is associated with the presence of leukaemia of small lymphocytes of B cell type (B-CLL). Although extensively studied from the viewpoint of the circulating leukaemic cells, the organisation of the neoplasm in the affected lymph node or splenic tissue compartments is less well known. Because peripheral blood (Habeshaw et al., 1979) and marrow involvement by neoplastic small lymphocytes is not of itself sufficient for a diagnosis of MLL of B cell type, a heterogeneous group of small cell lymphoid neoplasms, of both B and T cell type has been included in many studies of this disorder.
In this paper the morphological, phenotypic and immunohistological characteristics of the affected tissues in malignant lymphocytic lymphoma accompanied by B cell chronic lymphocytic leukaemia are reported, with particular attention paid to the proliferation centres, which can be studied only in tissue sections. Evidence is presented. showing that proliferation centres (PC) are not simply sites of increased mitotic activity, but are phenotypically distinct from the surrounding small lymphocytes. These intraclonal phenotypic differences are similar to reported variation in phenotype induced in CLL cells by exposure to phorbol ester. Since the ontogeny of the CLL B cell and its relationship to other B cell classes is unclear, as is the role of T cells in this (Lennert, 1978) ; Lukes/Collins -small lymphocytic lymphoma (B type) (Lukes & Collins, 1974) were selected because they had a splenectomy and/or lymph node biopsy, and had at least one immunological study of involved tissue. Pretreatment data were available in 21 patients. Fourteen had a peripheral blood lymphocyte count > 15 x 1091 1P at diagnosis and 5 of the remaining 6 subsequently did (one had a maximum count of 10.4 x 1091-1).
Survival was calculated using life table analyses with comparison of survivals evaluated using the log rank test (Peto et al., 1977) . Other statistical comparisons were done using the Fisher exact test and Chi square test.
Materials and methods
Histopathologic review All histologic sections were reviewed (45 lymph nodes, 9 spleens and 1 appendix). Formalin or formal sublimate fixed paraffin embedded sections were stained with H and E and in most cases with periodic-acid-Schiff, Giemsa, methyl green pyroninalcian blue and for reticulin. In 21 patients the initial biopsy studied was prior to treatment (18 had been biopsied within 2 months of the original diagnosis), while in 5, treatment (4 chemotherapy, 1 splenic irradiation) precedeed biopsy. In 1 patient (biopsied elsewhere) the treatment status was unknown.
Immunological studies Cell suspensions were made from 24 lymph nodes and 7 spleens. Eighteen peripheral blood samples were also studied. In nine additional cases (not included in remainder of study) peripheral blood cells were examined by phenotyping before and after in vitro exposure to TPA (100 ng ml -1) and subsequent culture. Tissue preparation and phenotyping was performed as previously described (Habeshaw et al., 1979 (Habeshaw et al., , 1983 Endogenous alkaline phosphatase activity in frozen sections was detected as described in detail previously (Swerdlow et al., 1983) using the substrate naphthol AS-MX phosphate 0.025% pH8.6 (Sigma).
A brief summary of the reactivity of the antibodies and other reagents that identify B cells and their subsets based on our studies and a review of the literature are presented in Table I (a more detailed table  including the anti-T cell antibodies is in Swerdlow et al., 1983 Thirteen (out of 27) of the first biopsies (7/16 later biopsies) showed relatively discrete and round PC generally no larger than normal germinal centres. In the remaining cases the PC were more variable in size, often of irregular outline, and sometimes confluent. Eight of the 13 patients with the former type of PC at initial biopsy underwent splenectomy during the period of our study, whereas none in the latter group of 10 did (P=0.008). At the time of splenectomy, three of the hilar nodes showed larger irregular PC. One patient who had no PC also underwent splenectomy.
In contrast to the surrounding lymphoma cells, proliferation centre cells had more abundant pale cytoplasm and slightly larger nuclei with more dispersed chromatin (Figure 2 ). Some nuclei were eccentrically placed within the cell. A variable number of "paraimmunoblasts" (Lennert, 1978) with medium sized, more vesicular, round nuclei and a prominent nucleolus were also present. Typical immunoblasts were occasionally present within or outside the PC. Mitotic figures were often more frequent within the PC. Spleen Three patterns of splenic involvement occurred: in 2 cases the white pulp was predominantly involved (spleen weights 2400g, 2150g), in 2 cases there was diffuse involvement of both red and white pulp (600 g, 600 g), and in 5 cases there were focal nodule(s) up to 2.5cm in diameter in addition to red and white pulp infiltration (975, 2075, 2170, 2630, 3150g) . The tumour nodules, which appeared to represent coalescence of white pulp areas, had PC in 3 cases. In all cases except one, even in the absence of well defined PC, cells in the white pulp had definite (3 cases) or some (5) cytological features of PC cells (Figure 4 ). The cells in the red pulp in all spleens were small round lymphocytes with condensed chromatin. In one spleen fairly numerous transformed cells were present including bizarre forms, but these cells were not seen in the hilar lymph node or in a subsequent biopsy of involved vermiform appendix. (Table II) . In general frozen section staining for Ig was clearly positive and uniform throughout the lesions. IgD i.r. and peanut lectin, and all cases were negative for endogenous alkaline phosphatase (Table III) .
Antitransferrin receptor monoclonal OKT9 stained a variable, usually small, number of cells in almost all cases. The monoclonal BA-2, which stains germinal centre and "early" B cells, gave positive reactions in only 3 cases (vide infra).
Within the lesions, differential staining of the proliferation centres and splenic white pulp areas was noted with some antibodies (summarized in Table IV ). In lymph nodes, proliferation centres stained more strongly with OKT9 and with the (Table IV) . Differential staining of lymphoma cells in the spleen showed similar features to those described in lymph nodes. The involved splenic white pulp areas showed staining patterns analogous to the proliferation centres in the lymph nodes (OKT9T, 33.1 T with HLA-Dr expression equal). BA-2 expression was not a feature of splenic white pulp staining (3 cases tested).
Blood CLL cells exposed to TPA in vitro showed consistent increases in the expression of HLA-DC antigen (monoclonal 33.1) and of HLA-DR (monoclonal Ca2-11) (9 cases 
Discussion
The contribution of yet another study of B-CLL to the already voluminous literature needs to be justified. In particular, the selection criteria applied in this study required that all patients had one or more tissue biopsies typical of malignant lymphocytic lymphoma as defined in the Kiel (Lennert, 1978) or Lukes/Collins classifications (Lukes & Collins, 1974) , equivalent to the Rappaport class of well differentiated lymphocytic lymphoma. In addition, all patients had at least one phenotypic study of involved tissue confirmatory of or compatible with this diagnosis. The occasionally similar appearances of marrow or peripheral blood involvement in other lymphomas, for example lymphoplasmacytoid or centrocytic lymphoma of small cell type, cautions that blood cell or bone marrow cytology alone form inadequate criteria for a definitive diagnosis of lymphocytic lymphoma.
Tissue sections, which provide evidence of cellular organisation not present in marrow or tissue cell suspensions, are an important element in establishing this diagnosis.
In MLL/B-CLL, proliferation centres with their characteristic larger and cytologically distinctive cells (Lennert, 1978) can be recognised and studied only in tissue section. Although generally the phenotypic features of circulating B-CLL cells have been assumed or reported to be similar to those in tissues, differences in the proportions of mouse RBC rosette forming cells have been reported (Braylan et al., 1976; Cherchi & Catovsky, 1980; Kettman et al., 1983) .
The contribution that immunohistological studies can make to understanding this defined class of disease is two-fold: 1) examining the relationship of the phenotypically distinct proliferation centre to the unorganized circulating B cell component of the tumour, and (2) (Lennert, 1978) , which is characterized by the absence of true plasma cells but has small lymphocytes with well developed plasmacytoid features. Proliferation centres are distinct from germinal centres or primary follicles, (and their neoplastic equivalents), lacking the follicular dendritic reticulum cell and the phenotypically and morphologically distinctive "cleaved cell" population of centrocytes and centroblasts always found in neoplasms of true follicular derivation (Stein et al., 1982) . In lymph nodes involved by MLL, the proliferation centres show no consistent anatomical localization. In the spleen, proliferation centres and their equivalent cells are found exclusively in the white pulp. The association in this series between the early appearance of discrete, round proliferation centres in nodes and the subsequent need for splenectomy indicates some connection between proliferation centres of this type and the biological behaviour of the disease. In our limited series, the approximate area of node occupied by proliferation centres could not be definitely related to a shorter survival (P= 0.06), and others have found no prognostic significance (Dick & Maca, 1978) . The previously documented relationship between mitotic rate and prognosis in MLL (Evans et al., 1978) , the concentration of mitotic figures in PC, increased staining of PC for the transferrin receptor with OKT9 and a previously reported retrospective study showing a correlation between OKT9 levels and survival in non-Hodgkin lymphoma (Habeshaw et al., 1983) all suggest that some relationship between PC formation and prognosis may still be found.
Cells of the proliferation centres always expressed the same Ig class as the small lymphocytes of the neoplasm. Loss of IgD staining in proliferation centres has been reported (Stein et al., 1980) . B-CLL cells have also been reported to lose IgD expression following exposure to TPA (Cossman et al., 1983; Totterman et al., 1981 (Okamura et al., 1982; Totterman et al., 1981a) , as well as HLA-Dc expression with the monoclonal antibody Genox 353 (Guy et al., 1983) . Increased staining of PC with the monoclonal 33.1 which detects a distinct DC-related Class II molecule (Marti et al., 1983) (Cossman et al., 1983; Forbes et al., 1981; Maeda & Deegan, 1983; Okamura et al., 1982; Totterman et al., 1980 Totterman et al., , 1981a . These effects represent, probably, quantitative changes rather than "differentiation" events, in that CLL cells can secrete IgM (Stevenson et al., 1980 (Stevenson et al., , 1982 , and monoclonal clg has been reported to be present in most cases of CLL (Gordon et al., 1983a; Guglielmi et al., 1982 , Han et al., 1982 Johnstone et al., 1982; Yasuda et al., 1982; Newell et al., 1983 Martin et al., 1981; Nanba et al., 1977) . B-CLL cells are morphologically and phenotypically distinct from germinal centre cells . B-CLL cells do show phenotypic similarities with B cells cells found in foetal or neonatal life (Gordon et al., 1983a; Johnstone, 1982) . In common with other workers, we have found in many instances IgG on CLL cells which is reported to represent binding by Fc receptors (Preud'homme & Seligmann, 1972) , or to be due to rheumatoid factor-like activity. Cases apparently expressing IgG have shown idiotypic differences from the cell associated IgM, or IgM and D (Stevenson et al., 1981) . However, even in a carefully selected group of patients with homogeneous disease we, and others, have not excluded the possibility of IgG expression (Godal & Funderud, 1982) . The reported excess of free light chain synthesis (Gathings et al., 1981; Gordon et al., 1983b) (Papadimitriou et al., 1979; Stein et al., 1980) , and is phenotypically similar. Multiple myeloma also exhibits a circulating CLLlike B cell population (Holm et al., 1977) with some phenotypic features of CLL cells. These findings suggest that CLL B cells would represent a precursor population of B lymphocytes destined to secrete antibody, but taking origin from a differentiation pathway which does not include the germinal centre. This pathway may be accessory to "mainstream" B lymphocyte development, in primary differentiation, and distinct from the T cell dependent, secondary humoral immune responsive memory and plasma cell pathway originating from germinal centre.
T cell populations in B-CLL are extensively documented, and of uncertain significance. Increases in peripheral blood T cells (Mills & Cawley, 1982; Platsoucas et al., 1982; Semenzato et al., 1981) especially of the "suppressor" subset, are not reflected in tissue sections or lymph node suspensions, where we find TH cells to be the predominant T cell type in most cases. Unlike the features of follicular neoplasms, where compartmentalization of TH cells (Tubbs et al., 1983) and "NK cells" (Tubbs et al., 1983; occur within the follicular lesions, both TH cells and Leu7+ cells occur as apparent random elements in MLL . T cells are not of the malignant clone in B-CLL (Gharton et al., 1980; Yunis et al., 1982; Fialkow et al., 1978) . T suppressor cells in our study were most commonly in the spleen, as others have shown (Kay et al., 1982 
